9th Annual Biomarkers Congress

Immunology: National Institutes of Health

Total Score People Score Events Score
59 47 27
Date Event Presentation Speakers
October 31, 2013 (T1) Keystone Symposia: Advancing Vaccines in the Genomics Era Genetic Dissection of Immunity Meeting has ended...abstracts no longer viewable online. Purchase an Abstract Book from this meeting Mary Carrington, Daniel Kastner
Genomic and Structural Approaches to Antigen and Adjuvant Discovery, Design and Validation Meeting has ended...abstracts no longer viewable online. Purchase an Abstract Book from this meeting Peter D. Kwong
April 6, 2013 AACR Annual Meetings BRAF Pathway Inhibitors in Melanoma: Where Do We Go from Here? Chairperson: Richard M. Marais, Paterson Institute for Cancer Research, Manchester, United Kingdom Deborah Morrison
The MICR Scientific Symposium: Why Are Aggressive Forms of Cancer More Common Among Certain Racial/Ethnic Groups? Co-Chairpersons: Christopher I. Li, Fred Hutchinson Cancer Research Center, Seattle, WA, and A. William Blackstock, Wake Forest University School of Medicine, Winston-Salem, NC Curtis C. Harris
Lymphoid Malignancies Co-Chairpersons: Peter J. Campbell, Wellcome Trust Sanger Institute, Cambridge, United Kingdom, and Louis M. Staudt, National Cancer Institute, Bethesda, MD Louis M. Staudt
Novel Therapeutic Concepts with Kinases, Immuno-, and Radiotherapy Chairperson: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY W. Marston Linehan
Predictive Modeling of Cancer Treatment in Single Patients (N of 1) Moderator: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY James H. DOROSHOW
Rational Combination Therapies in Cancer Chairperson: Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, TX Louis M. Staudt
Immune Reconstitution Following Lymphodepleting Cancer Therapy: Does It Matter? Crystal L. Mackall, National Cancer Institute, Bethesda, MD Crystal Mackall
December 2, 2012 Tumor Immunology: Multidisciplinary Science Driving Basic and Clinical Advances Session 6: Innovations in Adoptive T Cell Therapy James Chung-Yin Yang
Session 7: T Cell Precursors, Memory Subsets, and Control of Adoptive Therapy Nicholas P. Restifo
August 25, 2012 2012 Infectious Disease Board Review Course Clinical Immunology and Host Defense Steven M. Holland
November 18, 2011 BIT's 2nd Annual World Congress of Immunodiseases and Therapy 2011 Structural Immunology, HIV-1, and Vaccine Development Peter D. Kwong
April 14, 2011 Microbiota and Mucosal Immunology: The Interface in Health and Disease Pathogen and commensal induction of NOD1 signaling Warren Strober
April 12, 2011 New Insights into Normal versus Dysregulated B Cell Function (D6) Converging on the Achilles Heel of Lymphoma through Functional and Structural Genomics Louis M. Staudt
Seq-ing AID in B Cell Tumor Development R Casellas
Immunopathogenesis of B Cells in HIV Infection Susan Moir
February 26, 2011 Immunity in the Respiratory Tract: Challenges of the Lung Environment (X6) Mucosal Biology (X5) | Short Talk: TLR Agonists and/or IL-15 Adjuvanted Mucosal SIV-Vaccine Prevented Gut CD4+ Memory T Cell Loss After SIVmac251-Challenge in Macaques Yong Jun Sui
Mucosal Biology (X5) | Is the Direct Targeting of the Mucosa Necessary for an HIV Vaccine? Genoveffa Franchini
Mucosal Biology (X5) | Ocular Immune Privilege, T Regulatory Cells and Autoimmunity Rachel Caspi
Vaccines Inducing Pathogen-Specific Lung Immunity | Requirements for Immunity Against Pneumonic Tularemia Catharine . M. Bosio
Vaccines Inducing Pathogen-Specific Lung Immunity | Local Immunity Induced by Live Attenuated Pandemic Influenza Vaccines Kanta Subbarao
February 26, 2011 Mucosal Biology: A Fine Balance between Tolerance and Immunity (X5) LPS Promotes IL-35-Dependent Suppression of Allergen-Induced Airway Disease Donald N. Cook
The IL-13 Decoy Receptor Tightly Controls Pathogenic Th17 and Th2 Responses in the Mucosa Thomas A. Wynn
Viruses in Health and Disease | Short Talk: TLR Agonists and/or IL-15 Adjuvanted Mucosal SIV-Vaccine Prevented Gut CD4+ Memory T Cell Loss After SIVmac251-Challenge in Macaques Yong Jun Sui
Viruses in Health and Disease | Is the Direct Targeting of the Mucosa Necessary for an HIV Vaccine? Genoveffa Franchini
Control of Immune Responses in the Skin, Eye and Genital Tract | Ocular Immune Privilege, T Regulatory Cells and Autoimmunity Rachel Caspi
Immunity in Respiratory Tract (X6) | Requirements for Immunity Against Pneumonic Tularemia Catharine . M. Bosio
Immunity in Respiratory Tract (X6) | Local Immunity Induced by Live Attenuated Pandemic Influenza Vaccines Kanta Subbarao
February 12, 2011 Cancer Control by Tumor Suppressors and Immune Effectors (J8) Adaptive Immunity against Cancer? | Re-Imagining the Ideal Antitumor T Cell Nicholas P. Restifo
Translating Immune Responses Toward and Into the Clinic (Joint) | TLRs in Vaccine Development Robert Seder
January 9, 2011 NK and NKT Cell Biology: Specificity and Redundancy of Innate Responses (A4) NK and NKT Cells in Viral Infection | Immunogenetic variation characterizing exceptional control of HIV Mary Carrington
August 24, 2010 Enabling Point-of-Care Diagnostics - Moving Towards Rapid Diagnosis Retrospective Study, 1918 Pandemic Virus and 2009 H1N1: Lessons for POCT Jeffery K. Taubenberger
Exporting Cervical Cancer Prevention to the Developing World: The Promise and the Challenges Philip E Castle
May 20, 2010 Antibody Optimization Deimmunizing Non-Human Proteins Ira Pastan
Chairperson’s Remarks Ira Pastan
April 11, 2010 Molecular Targets for Control of Vector-Borne Diseases: Bridging Lab and Field Research (F2) * Systems Biology of the Immune Response | Big Horn B Peter D. Crompton
* Inducing Optimal Protective Responses with Vaccines | Big Horn B Joanna Kubler Kielb
August 18, 2009 Second Annual Pre-Clinical/Clinical Development of Immunotherapies and Vaccines Behavioral and Social Science Considerations for Clinical Research Chuen-Yen Lau
August 18, 2009 Inaugural Novel Vaccines: Adjuvants & Delivery Systems Adjuvant Properties of CpG Oligonucleotides Dennis M. Klinman
December 4, 2008 BIT Life Sciences 2nd Annual World Congress of Gene-2008 (WCG 2008) Identification of Novel Modifier Genes of Sox10 Neurocristopathy by a Functional Genomic approach : Track 1-3 Ling Hou
Application of Advanced Technologies to Personalized Oncology: Track 1-7 Francis S Collins
Biological Comparison of Human Anti-AMA1 IgGs :Track 2-9 Kazutoyo Miura
Development of Lentiviral Vectors for Studying on Gene Function, Gene Discovery and Gene Therapy :Track 2-12 Zhennan , Lai
December 1, 2008 European Antibody Congress 2008 Antibody variable and constant domains as scaffolds: domain antibodies and nanoantibodies Dimiter S Dimitriov
June 8, 2008 Malaria: Immunology, Pathogenesis and Vaccine Perspectives Immunology II Susan K. Pierce
Vaccines II Louis H. Miller
May 30, 2008 ASCO Annual'08 Meeting breast cancer-- Second Primary Cancers: New Population-Based Results and an Overview of Survivors at Risk Lois B. Travis
cancer genetics-- Neurofibromatosis Type 1: The Development and Treatment of Neural Tumors Brigitte C. Widemann
clinical trials-- The End of P Values? Why Alternative Methods to Making Inferences May Be Superior Steven Hirschfeld
developmental therapeutics-- DNA Repair Modulators Yves Pommier
genitourinary cancer-- Second Primary Cancers: New Population-Based Results and an Overview of Survivors at Risk Lois B. Travis
lymphoma and plasma cell disorders-- How to Interpret and Communicate the Risks of Therapy-Related Complications: Demystifying Epidemiologic Research (M08) Lois B. Travis
patient and survivor care-- How to Interpret and Communicate the Risks of Therapy-Related Complications: Demystifying Epidemiologic Research (M08) Lois B. Travis
patient and survivor care-- Second Primary Cancers: New Population-Based Results and an Overview of Survivors at Risk Lois B. Travis
pediatric cancer-- Neurofibromatosis Type 1: The Development and Treatment of Neural Tumors Brigitte C. Widemann
special sessions-- Opening Ceremony with Presidential Address, NCI Director’s Address, The ASCO Cancer Foundation Donor Appreciation Awards, and Karnofsky Memorial Award Lecture John E. Niederhuber
tumor biology-- Molecular and Pharmacokinetic Aspects of Brain Metastases (M04) Patricia Steeg
meet the professor sessions-- Molecular and Pharmacokinetic Aspects of Brain Metastases (M04) Patricia Steeg
meet the professor sessions-- How to Interpret and Communicate the Risks of Therapy-Related Complications: Demystifying Epidemiologic Research (M08) Lois B. Travis
April 8, 2008 Molecular Evolution as a Driving Force in Infectious Diseases Workshop Willem M. van Ballegooijen
April 8, 2008 Molecular Evolution as a Driving Force in Infectious Diseases Workshop Willem M. van Ballegooijen
April 8, 2008 Molecular Evolution as a Driving Force in Infectious Diseases Workshop Willem M. van Ballegooijen
March 25, 2008 CYTOKINE-BASED THERAPEUTICS CNS Inflammatory Diseases Charles E Egwuagu
March 2, 2008 MOLECULAR MECHANISMS IN LYMPHATIC FUNCTION & DISEASE TRANSCRIPTIONAL REGULATION OF ADIPOGENESIS AND LYMPHANGIOGENESIS Brant Weinstein
Studying early lymphatic development using the zebrafish Brant Weinstein
February 3, 2008 TGF-ß Family in Homeostasis and Disease Cancer I Lalage M. Wakefield
November 29, 2007 MOLECULAR AND IMMUNOLOGICAL APPROACHES TO VACCINE DESIGN Vaccines in the Young and the Old Robert Seder
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.